VERA Similar Chart Price Prediction
The price of VERA is predicted to go up 4.35%, based on the high correlation periods with MX. The similarity of these two price pattern on the periods is 95.18%.
VERA
MX
Up: 4.35%Similarity: 95.18%
VERA Revenue Forecast
VERA EPS Forecast
VERA FAQs
What is bull’s view on VERA?
What is bear's view on VERA?
VERA Analyst's Forecast
Vamil Divan
Guggenheim
Strong Buy
2024-10-28
Price Target
$56 → $64
Upside
+35.19%
Guggenheim raised the firm's price target on Vera Therapeutics to $64 from $56 and keeps a Buy rating on the shares. After attending the American Society of Nephrology meeting this weekend, the firm says it "once again came away impressed" with the clinical profile for Vera's atacicept in the treatment of immunoglobulin A nephropathy, or IgAN. Following the ASN meeting, the firm increased its atacicept probability of success view to 85% from 80% and its market penetration rates for the APRIL/BAFF class and for atacicept specifically, the analyst tells investors.
Greg Harrison
Scotiabank
Buy
2024-10-16
Price Target
$60
Upside
+50.04%
